RobertKaplanMDAttending Physician

PubMed

• 29 citations
  Successful plasma exchange combined with rituximab therapy in aggressive APS-related cutaneous necrosis.
  Rubens Costa, Salman Fazal, Robert B. Kaplan, Joel A. Spero, Ricardo Lima Barros Costa
  Clinical Rheumatology. 2013-03-01
• 6 citations
  Aggressive Disease and Rare Sequelae in a Unique Case of Atypical Hemolytic Uremic Syndrome Secondary to Adult Onset Still's Disease.
  Ahmed Khattab, Amulya Yellala, Jyothika Mamadgi, Sunita Patruni, Robert B. Kaplan
  Journal of Hematology. 2019-07-06
• 72 citations
  Internet Patient Decision Support: A Randomized Controlled Trial Comparing Alternative Approaches for Men Considering Prostate Cancer Screening
  Dominick L. Frosch, Vibha Bhatnagar, Steven R. Tally, Charles J. Hamori, Robert M. Kaplan
  Archives of Internal Medicine. 2008-02-25

Journal Articles

• Successful Plasma Exchange Combined with Rituximab Therapy in Aggressive APS-related Cutaneous Necrosis  
  Costa R, Fazal S, Kaplan R, Spero J, Costa R, Clin Rheumatology, 6/17/2010
• Preoperative Management of a Patient with Hypoprothrombinemia-Lupus Anticoagulant Syndrome  
  Raflores M., Kaplan R., Spero J, Thrombosis and Haemostasis, 1/1/2007
• Treatment of Acute Myelogenous Leukemia with Outpatient Azacitidine  
  Sudan N, Rossetti, JM, Shadduck RK, Latsko J, Lech JA, Kaplan R, Kennedy M, Gryn JF, Faroun Y and Lister J, American Cancer Society,Wiley Interscience, 1/1/2006
• Induction and Maintenance Therapy of Acute Myelogenous Leukemia with Outpatient Azacitidine  
  RK Sudan N, Rossetti JM, Shadduck RK, Lister J, Lech JA, Kaplan R, Kennedy MK, Faroun Y, Latsko J, Cancer, 1/1/2005
• Subcutaneous Lepirudin for Heparin-Induced Thrombocytopenia and When Other Anticoagulants Fail: Illustrative Cases  
  Steven R. Deitcher, MD, Raphael Ngengwe, Robert Kaplan MD, Howard Liebman,MD, Karen Kaplan, MD, Morey Binder, MD, Clinical Advances in Hematology & Oncology, 6/1/2004
• Combined Defect in Membrane Expression and Activation of Platelet GPIIb-IIIa Complex without Primary Sequence Abnormalities in Myeloproliferative Disease  
  R. Kaplan, J. Gabbeta, L. Sun, G. Mao, A.K. Rao, British Journal of Hematology, 1/1/2000
• Inherited Thrombophilic States  
  A.K. Rao, R. Kaplan, S. Sheth, Inherited Thrombophilic States, 1/1/1998
• Mechanisms of the Coagulopathy Associated with Acute Promyelocytic Leukemia  
  R. Kaplan, R. De la Cadena, American Journal of Hematology, 1/1/1998
• Inherited Hypercoagulable States  
  A K Rao, S Sheth, R. Kaplan, Vasc Med, 1/1/1997
• Join now to see all

Abstracts/Posters

• In-Hospital Complications and Outcomes of Autologous Stem Cell Transplantation in Multiple Myeloma Patients Older Than 65-Years Old in the United States: National Inpa...
  Robert B. Kaplan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Response to Azacitidine in patients with Secondary Myelodysplastic Syndrome
  Abdulhaq H, Rossetti JM, Shadduck RK, Lister J, Lech J, Kaplan R, Kennedy M, Latsko J, Kramer W, Journal of Clinical Oncology, 6/1/2006
• Response and Tolerability of a 5-day Azacitidine Schedule in Patients with Myelodysplastic Syndrome
  Abdulhaq H, Rossetti JM, Shadduck RK, Lister J, Lech JA, Kaplan R, Kennedy M, American Society of Clinical Oncology 2006 Annual Meeting, 1/1/2006
• Reduced Intensity Unrelated Peripheral Blood Stem Cell Transplant: Comparison of Two Regimens
  Raflores M, Rossetti JM, Kaplan R, Lech JA, Kennedy M, Schunn G, Shadduck RK, Lister J, National Marrow Donor Program (NMDP) Council Meeting, 11/1/2005
• Allogeneic and Matched Unrelated Donor Hematopoietic Stem Cell Transplantation (HSCT) for Hematologic Malignancies Using a Modified Reduced Intensity Conditioning Regimen
  Raflores M, Rossetti JM, Lister J, Shadduck RK, Lech J, Kaplan R, Kennedy M, Schunn G, Pennsylvania Society of Oncology and Hematology (PSOH) Annual Meeting, Harrisburg, PA, 9/1/2005
• AML Induction Therapy with Outpatient Azacitidine
  Shadduck RK, Rossetti JM, Faroun Y, Kaplan R, Lister J, 46th Annual Meeting of the American Society of Hematology, Blood, San Diego, CA, 12/1/2004
• AML Induction Therapy with Outpatient Azacitidine
  Shadduck RK, Rossetti JM, Faroun Y, Kaplan R, Lister J, Blood, 11/1/2004
• Impaired Iron Absorption in 2004
  Miske HR, Shadduck RK, Lister J, Kaplan R, Lech J, Kennedy M, Schunn, G, Rossetti JM, Pennsylvania Oncology and Hematology Society Meeting, Pittsburgh, PA, 9/1/2004
• Very Low Platelet Count in Post-Transfusion Purpura vs Heparin Induced Thrombocytopenia
  Faroun Y, Shadduck RK, Gryn JF, Kaplan R, Lieb J, Miske H, Pennsylvania Oncology and Hematology Society Meeting, Valley Forge, PA, 9/1/2003
• Lepirudin as Chronic Anticoagulation in Hypercoagulable Patients with Multiple Anticoagulant Failures: A Retrospective Case Series
  Miske H, Zeigler Z, Kaplan R, Pennsylvania Oncology and Hematology Society Meeting, Valley Forge, PA, 9/1/2003
• Reduced Intensity Peripheral Blood Stem Cell Transplant from Matched Related and Unrelated Donors
  Rossetti JM, Shadduck RK, Gryn JF, Zeigler ZR, Kaplan R, Lister J, The Western Pennsylvania Hospital Resident Research Day, 5/1/2003
• Whole Blood Aggregation and Measurement of Platelet Factor 3 Availability but Not Platelet-Rich Plasma Aggregation Studies Detects Platelet Function Abnormalities in P...
  R. Kaplan, Zella Rose Zeigler, Richard K. Shadduck, John Lister, Proceedings of the American Society of Hematology, 12/1/2002
• Paclitaxel by 1-hour Infusion Combined with Carboplatin in Advanced Non-small Cell Lung Carcinoma (NSCLC): A Phase II Study
  C Langer, R. Kaplan, E. Rosvold, M Millenson, MR Smith, C Johnson, R Kosierowski, C McAleer, C Bonjo, R Ozols, Proceedings of the American Society of Clinical Oncology, 5/1/1996
• Join now to see all

Lectures

• The Risk Factors of the Venous Thromboembolism in Hospitalized Patients with Hematologic Malignancies in the United States: National Inpatient Sample Analysis, 2011-2015 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Pharmacologic Approaches to the Management of Venous Thromboembolic Diseases and Heparin-Induced Thrombocytopenia 
  Buffalo, New York - 4/4/2007
• Advances in Anticoagulation for the Management of Venous Thromboembolic Disease and Heparin-Induced Thrombocytopenia 
  Johnstown, Pennsylvania - 10/11/2006
• Advances in Anticoagulation for the Management of Venous Thromboembolic Disease 
  Radisson Hotel, Monroeville, Pennsylvania - 10/7/2006
• Hypercoagulable Disorders: Part I-Hereditary 
  9/20/2006
• Blood in Motion 
  The Western Pennsylvania Hospital - 5/13/2006
• Evaluation of Thrombocytopenia/Bleeding Tendency 
  12/7/2005
• Diagnosis and Management of Common Types of Anemias 
  5/18/2005
• The Threat of DVT 
  The Western Pennsylvania Hospital - 5/14/2005
• Recognizing HIT in the ER Setting/The Role of Arixtra in Current Anticoagulation Management 
  Pittsburgh, Pennsylvania - 4/14/2005
• Berlex HIT (Heparin-Induced Thrombocytopenia) Speaker's Bureau 
  Canton, Ohio - 9/8/2004
• The Future of Refludan-Subcutaneous Dosing and Uses in non-HIT Settings 
  New Orleans, Louisiana - 6/6/2004
• The Future of Refludan-Subcutaneous Uses/The Western Pennsylvania Hospital Experience 
  The Ritz Carlton, Orlando, Florida - 3/13/2004
• Join now to see all